<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS CONTAINED IN THE COMPANY'S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000,000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> MAR-31-1999 <CASH> 114 <SECURITIES> 1,204 <RECEIVABLES> 390 <ALLOWANCES> 21 <INVENTORY> 117 <CURRENT-ASSETS> 1,973 <PP&E> 2,127 <DEPRECIATION> 645 <TOTAL-ASSETS> 3,818 <CURRENT-LIABILITIES> 852 <BONDS> 223 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 0 <OTHER-SE> 2,743 <TOTAL-LIABILITY-AND-EQUITY> 3,818 <SALES> 688 <TOTAL-REVENUES> 746 <CGS> 92 <TOTAL-COSTS> 92 <OTHER-EXPENSES> 188<F1> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 2 <INCOME-PRETAX> 346 <INCOME-TAX> 99 <INCOME-CONTINUING> 247 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 247 <EPS-PRIMARY> 0.48<F2> <EPS-DILUTED> 0.46 <FN> <F1>ITEM CONSISTS OF RESEARCH AND DEVELOPMENT EXPENSES. <F2>"EPS-PRIMARY" DENOTES BASIC EPS. </FN>